Landmark research yields cutting-edge treatment for AD!!

The scientists at the Federal Polytechnic School in Lausanne have developed a capsule that can be implanted under skin tissue to safely deliver a steady flow of antibodies to the patient’s brain. The antibodies trigger the immune system to target amyloid beta plaques and prevent the formation of new plaques.
Early tests had great, dramatic success.